The brillant literature review and health risk assessment by Mennear and ChengChung, "Polybrominated Dibenzo-p-dioxins and Dibenzofurans: Literature Review and Health Assessment" [EHP 102(suppl 1):265-274], states that "reports of human toxicity associated with exposure to PBDDs and PBDFs were not found" (p. 272). In fact, in their review, no references are discussed or quoted regarding human studies.
Human Toxicity of PBDDs and PBDFs
The brillant literature review and health risk assessment by Mennear and ChengChung, "Polybrominated Dibenzo-p-dioxins and Dibenzofurans: Literature Review and Health Assessment" [EHP 102(suppl 1):265-274], states that "reports of human toxicity associated with exposure to PBDDs and PBDFs were not found" (p. 272) . In fact, in their review, no references are discussed or quoted regarding human studies.
Two papers have been published on the human toxicology of these compounds. The first (1) is a recent report, previously presented at the Dioxin '90 Congress (2) , about a chemist who was exposed to 2,3,7,8,-tetrabromodibenzodioxin (TBDD) and to 2,3,7,8-tetrachlorodibenzodioxin (TCDD) in March and September 1956, respectively, when synthesizing these chemicals. The chemist was defined as "in good health" in 1990, when determinations of chlorinated and brominated dioxins and dibenzofurans were performed on whole blood. High concentrations of several congeners were detected, and the results were used to discuss the half-life of the chemicals in humans. The subject presented a mild chloracne after an unspecified time from his exposure to bromodixoins in March, suggesting that TBDD could produce skin effects as chlorodioxins. Other more relevant symptoms occurred after the exposure to TCDD in September, and the patient was hospitalized for a short period.
The second was a study of subjects exposed to PBDDs and PBDFs as a result of working at a BASF factory in etrusion blending of polybutyleneterphthalate with decarbromodiphenyl ether, used as a flame retardant. The intensity of exposure was determined in 1989 through air monitoring (3). The paper presents blood levels of 2,3,7,8,-TBDF and TBDD and of total congener profiles for some exposed workers and the results of a comparison of several immunological tests in a population of exposed versus a population of unexposed deriving from the same working cohort. Workers had detectable blood levels of TBDD and TBDF; half-life estimates of these chemicals are presented. The results of immunological tests were described as "not adversely impacted at these burdens of PBDFs and PBDDs," even though the results of several tests showed a correlation with exposure, and in the subject having the highest blood levels of PBDFs (1) .
Critique: The average arsenic exposures in almost all of the studies analyzed were too low to observe methylation saturation.
Response: The commentators base this statement on three issues. First, the authors state that evidence from an experimental study (of only four human volunteers each receiving only one dose level) suggests that methylation would be completely saturated at exposures greater than 500 pg/day (3) .
However, at the highest oral dose in this study, 1000 pg/day, the amount of urinary arsenic in the inorganic form was only 26%, hardly demonstrating methylation saturation even at this level. Buchet Second, the authors state that we analyzed only two groups with average urinary arsenic levels at or above 190 pg/I, which they hypothesize corresponds to the concentration above which methylation saturation occurs. This statement obscures the fact that 1) the two groups combined had a total of 35 people, 2) our analysis of available individual data (see Figure 2 of our paper) included 14 persons with urinary arsenic levels >190 pg/l. No trend of higher relative proportions of unmethylated arsenic is suggested for those 14 individuals.
Third, the authors state: ". . . a regression analysis on the individual data within the Yamauchi et al. [4] population was borderline significant at p = 0.10. . ." (p. 354). However, this was just one of nine regression analyses we presented. The slopes were positive in four (including the Yamauchi study) but negative in five (1: Table 9 ).
As a matter of interest, in our more recent studies of chronically exposed popu-nations in the United States and Chile, we have urinary speciation data for over 100 individuals exposed to average levels well above 1000 pg As/day and ranging above 2000 pg/day with no evidence of methylation saturation even at these levels. Our study in Nevada of 18 chronically exposed individuals also found no evidence of methylation saturation, even with an average estimated intake of 2260 pg As/day (5) .
If a methylation threshold for arsenic does exist, the epidemiological and experimental evidence suggest that it must be at exposure levels well above 2000 pg/day, making it completely irrelevant to usual human exposures and adverse health outcomes.
Critique We used urinary arsenic concentrations from grab samples as the basis for evaluating methylation capacity. However, the proportion of inorganic arsenic excreted in the urine varies with time; thus an individual grab sample is not representative of the degree of methylation that is occurring.
Response This concern would apply to small studies of short-term exposures, such as those of experimental studies of human volunteers or incidents of accidental or self-induced poisoning. Our critics again cite as an example Buchet et Response Relative to the exposed populations, the intake of the control populations was virtually zero. Nonetheless, examination of the graphs in Figure 1 of our paper would show that the doseresponse slopes would actually increase rather than decrease if one assumed a higher exposure for the control population.
Critique: Smith et al. did not discuss the implications of detoxification in estimating potential risks from low-level exposures typical of the U.S. population.
Response: We did. A whole section of our paper is devoted to it: "Is There a Threshold?" Response: We have discussed this topic in detail in another paper published by our group (6) which we referenced in our methylation article. In brief, there is little, if any, valid evidence to support the claim that humic substances contribute to increased cancer occurrence in the arsenicendemic areas of Taiwan.
Critique: We do not address the differences between the Taiwanese and U.S. populations that would reduce the accuracy of using exposure-response data from Taiwan for U.S. populations. We then make reference to protein and methionine intake.
Response: We did. A paragraph in the section titled "Risk Estimation for the U.S. Population" addresses this issue. For example, in reference to protein deficiency, we state: "If nutritionally inadequate diets among the Taiwanese population exposed to arsenic made them more susceptible to the carcinogenic effects of arsenic, the extrapolated risk estimates for the average U.S. population would be too high" (2: 264). However, a reanalysis of the data presented in the paper referenced by our critics (7) shows that by current standards the Taiwanese intake of protein and methionine was adequate (8) .
Carlson-Lynch et al. further claim that our exposure parameters in terms of drinking water intake in Taiwan were too low. We would merely note that we used published EPA estimates of Taiwanese drinking water intake (9) . If one used higher estimates, then cancer risk estimates for the U.S. would indeed be a little lower. However, the estimate of 4.5 liters of arsenic-containing water per day that they refer to comes from a speculative EPA staff discussion with virtually no data to support it (10) . In our view, the previous estimate of 3.5 liters/day has just as much plausibility for an all-year average for males in a warm, but temperate, climate.
However, it is a moot point since thiSvanlable has only a small effect on risk estimates.
Finally, in the brief paragraph of the article not devoted to criticism of our studies, the authors state that mechanistic or more refined epidemiological studies are needed to assess the relationship between internal cancers and arsenic ingestion. On this we can agree. They then cite as an example an article by Guo et al. (11 Water ingestion rates also can significantly affect total arsenic exposure and the calculation of cancer slope factors. As discussed in our commentary, EPA has recently approved an RfD for arsenic based on Taiwanese data and a water consumption rate of 4.5 1/day for males and females (7) . While it is true that EPA had previously estimated Taiwanese water intake to be 3.5 1/day for males and 2 1/day for females (8) , the characterization by Smith et al. that the more recent estimate of 4.5 1/day comes from "a speculative EPA staff discussion with virtually no data to support it" is inappropriate. Abernathy and his colleagues considered discussions of water consumption rates with several individuals from a Taiwanese Blackfoot treatment cen-
